Numeta G16e (Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio)

Numeta G16e delivers a balanced mixture of essential amino acids for patients who cannot receive nutrition through the gastrointestinal tract.

• Parenteral nutrition: supplies the amino acids needed for protein synthesis in patients dependent on intravenous feeding.
• Critical‑care nutrition: helps meet the heightened metabolic demands of ICU patients.
• Pre‑ and post‑operative support: provides amino acid substrates to aid recovery after major surgery.

• Numeta G16e is an intravenous amino acid solution that bypasses the gastrointestinal tract, delivering essential amino acids directly into the bloodstream. These amino acids become substrates for ribosomal protein synthesis, support nitrogen balance, and replenish intracellular pools required for tissue repair, immune function, and metabolic processes in patients unable to ingest nutrients orally or enterally.

Numeta G16e may be associated with infusion‑related and metabolic reactions.

Common Side Effects

• Hyperglycemia: elevated blood glucose levels during infusion.
• Electrolyte imbalance: changes in potassium, sodium or calcium concentrations.
• Infusion site irritation: redness, pain or phlebitis at the catheter site.
• Nausea or mild vomiting.
• Metabolic alkalosis: shift in acid‑base balance.
• Mild hepatic enzyme elevation.

Serious or Rare Side Effects

• Anaphylactic reaction: severe allergic response requiring immediate intervention.
• Severe metabolic acidosis: rapid drop in blood pH.
• Renal impairment: worsening kidney function in susceptible patients.
• Hepatic dysfunction: significant liver enzyme rise or cholestasis.
• Thrombophlebitis: clot formation with vein inflammation.
• Severe electrolyte disturbances: life‑threatening hyper‑ or hypo‑kalemia.

When using Numeta G16e, clinicians should observe several safety measures.

• Renal function assessment: evaluate creatinine clearance before and during therapy.
• Electrolyte monitoring: check serum potassium, sodium, calcium and magnesium regularly.
• Blood glucose control: monitor glucose levels, especially in diabetic patients.
• Hepatic status review: adjust dosing if liver enzymes are markedly elevated.
• Aseptic technique: ensure sterile handling of the IV solution to prevent contamination.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Numeta G16e can interact with other intravenous agents and systemic medications.

Major Interactions (Avoid)

• High‑dose potassium chloride: risk of severe hyperkalemia when combined.
• Calcium gluconate: potential precipitation of calcium‑phosphate complexes.
• Large amounts of vitamin C: may increase oxalate load and renal stone risk.

Moderate Interactions (Monitor Closely)

• Loop diuretics: may exacerbate electrolyte shifts during amino acid infusion.
• Insulin therapy: concurrent use may require tighter glucose monitoring.
• Other parenteral nutrition components: adjust total nutrient load to avoid over‑feeding.